The bank upgraded the digital platform for medical professionals to a strong buy from outperform.
Get this delivered to your inbox, and more info about our products and services.
The bank initiated the stock with an outperform rating.
Morgan Stanley sees shares of Doximity rising 48% from here.
Frank Holland breaks down what traders are watching ahead of the new session.
We're making our third sale of this health-care stock since its earnings sell-off.
Leerink analysts lifted J&J shares to a buy equivalent from hold on Wednesday, citing the company's slate of new drugs.
Josh Brown and Sean Russo break down this stock that could be ready to rip higher.
